1. Home
  2. KEQU vs CING Comparison

KEQU vs CING Comparison

Compare KEQU & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$34.43

Market Cap

97.9M

Sector

Industrials

ML Signal

N/A

CING

Cingulate Inc.

HOLD

Current Price

$5.24

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
CING
Founded
1906
2012
Country
United States
United States
Employees
N/A
13
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.9M
93.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
KEQU
CING
Price
$34.43
$5.24
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$34.50
AVG Volume (30 Days)
4.1K
542.3K
Earning Date
03-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.09
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.64
N/A
Revenue Growth
7.72
N/A
52 Week Low
$30.33
$3.20
52 Week High
$60.89
$11.89

Technical Indicators

Market Signals
Indicator
KEQU
CING
Relative Strength Index (RSI) 48.65 37.37
Support Level $33.70 $3.62
Resistance Level $41.26 $6.85
Average True Range (ATR) 0.66 0.52
MACD 0.31 -0.14
Stochastic Oscillator 93.66 8.15

Price Performance

Historical Comparison
KEQU
CING

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: